🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Immunological and tumour characterization

Found 17 matching trials

Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice

N/A

This a prospective, multicenter, observational pharmacological translationa...

Status

Not Yet Recruiting

Location

Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS

Start Date

2026-10

Trial ID

NCT07767799

Treatments Being Tested

WP1 - Task 1 - Liquid analyses WP1 - Task 2 - Immunological analyses WP1 - Task 3 - Tumor tissue analyses WP1 - Task 4 - Imaging analyses WP1 - Task 5 - Microbiome and metabolomics analyses WP2 - Task 1 - Liquid analyses WP2 - Task 2 -Immunological analyses WP2 - Task 3 - Tumor tissue analyses WP2 - Task 4 - Imaging analyses WP2 - Task 5 - Microbiome and metabolomics analyses WP3 - Task 1 - Liquid analyses WP3 - Task 2 - Immunological analyses WP3 - Task 3 - Tumor tissue analyses WP3 - Task 4 - Imaging analyses WP3 - Task 5 - Microbiome and metabolomics analyses

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

N/A

Aim of this study is to characterize the chemical/physical and structural p...

Status

Unknown

Location

European Institute of Oncology

Start Date

2024-05-27

Trial ID

NCT06474988

Treatments Being Tested

Skin tests

Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology

Currently, the molecular characterization of onco-hematological, onco-immun...

Status

Recruiting

Location

Meyer Children's Hospital IRCCS

Start Date

2023-07-05

Trial ID

NCT06304194

Treatments Being Tested

Analysis of biological samples

Study of Biomarkers in Gynecological Cancers

In recent years, there has been a significant improvement in understanding ...

Status

Recruiting

Location

Princess Margaret Cancer Centre

Start Date

2017-12-21

Trial ID

NCT03420118

Treatments Being Tested

Tumour tissue collection Blood draws

Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors

N/A

Over the last 10 years, technological advances in molecular biology enabled...

Status

Unknown

Location

AP-HP Jean Verdier Hospital

Start Date

2017-05

Trial ID

NCT03149523

Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

N/A

Paraneoplastic neurological syndromes are rare syndromes caused by the remo...

Status

Active Not Recruiting

Location

Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est

Start Date

2024-05-01

Trial ID

NCT06620913

Treatments Being Tested

Description of clinical, immunological and tumor features of patients harboring CV2 Abs

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

PHASE1

RATIONALE: Vaccines made from a person's tumor may help the body build an i...

Status

Completed

Location

Roswell Park Cancer Institute

Start Date

1997-08

Trial ID

NCT00003974

Treatments Being Tested

lung tumor associated antigen DetoxPC chemotherapy cyclophosphamide

Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

N/A

This pilot/exploratory study will be configured as a non-retro-prospective ...

Status

Unknown

Location

"Regina Elena" National Cancer Institute

Start Date

2022-12-13

Trial ID

NCT06250010

Treatments Being Tested

tissue samples (healthy and tumor taken from the same patient) and tissue samples (decidualized endometrium and trophoblast taken from it patient)

Clinical-immunological Features of DNER Ataxia

N/A

Using a retrospective cohort of 34 patients with DNER ataxia, we will chara...

Status

Unknown

Location

HCL Hôpital Neurologique / Groupement EST

Start Date

2021-06-15

Trial ID

NCT05225896

Treatments Being Tested

Description of clinical characteristic and genetic tumors

DOD Long-Term Survivors of Ovarian Cancer

: Stages III and IV serum ovarian cancer are the most lethal of all gynecol...

Status

Unknown

Location

Massachusetts General Hospital (The General Hospital Corp)

Start Date

2014-09

Trial ID

NCT02321735

Treatments Being Tested

Quality of life questionaire

Previous Next